期刊文献+

基质金属蛋白酶抑制剂对动脉粥样硬化形成的影响 被引量:1

The Effects of Matrix Metalloproteinases Inhibitors on Atherosclerosis
下载PDF
导出
摘要 基质金属蛋白酶是一种酶活性Zn2+依赖性肽链内切酶家族,它们能溶解结缔组织和细胞外基质的多种成分,并能使一些正常和病理性组织发生重构,从而导致了动脉粥样硬化的形成。基质金属蛋白酶抑制剂作为基质金属蛋白酶的特异抑制剂,能够抑制基质金属蛋白酶及其前体的活性。基质金属蛋白酶/基质金属蛋白酶抑制剂的平衡破坏对于动脉粥样硬化形成起了重要作用。 Matrix metalloproteinases ( MMPs ) are zinc-dependent endopeptidases belonging to a family of proteases known as metzincins. MMPs are not only involved in the connective tissue and the degradation of extracellular matrix components, they are also involved in some normal and pathological tissue remodeling which leads to the formation of atherosclerosis. Matrix metalloproteinases inhibitors ( TIMPs ) are the specific inhibitors of MMPs, and can inhibit the activity of MMPs and their precursor. Disruption of the balance between MMPs and TIMPs plays an important role in atherogenesis.
出处 《心血管病学进展》 CAS 2012年第5期620-622,共3页 Advances in Cardiovascular Diseases
关键词 基质金属蛋白酶 基质金属蛋白酶抑制剂 动脉粥样硬化 细胞外基质 matrix metalloproteinases matrix metalloproteinases inhibitors atherosclerosis extracellular matrix
  • 相关文献

参考文献22

  • 1Jones LE, Humphreys MJ, Campbellf F, et al. Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 prgdicts poor survival [J]. Clin Cancer Res,2004,10 ( 8 ) : 2832-2845.
  • 2Beaudeux JL,Giral P,Bruckert E ,et al. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives [ J ]. Clin Chem Lab Med ,2004,42 (2) :121-131.
  • 3Yamamoto H, Iku S, Adachi Y, et al. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer [ J ]. J Pathol,2003,199(2) :176-184.
  • 4Huang W, Li WQ, Dehnade F, et al. Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage [ J ]. J Cell Biochem ,2002,85 ( 2 ) :295 -303.
  • 5Basu P, Sen U,Tyagi N, et al. Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function [ J ]. Vasc Health Risk Manag ,2010,6( 1 ) : 215-228.
  • 6Danesh J, Wheeler JG, Hirschfield GM,et al. C-reactive protein and other circu- lating markers of inflammation in the prediction of coronary heart disease[J]. N Engl J Med,2004,350(14) :1387-1397.
  • 7Higashikata T, Yamagishi M, Higashi T, et al. Altered expression balance of ma- trix metallopreteiuases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method[J]. Ath- eresclerosis ,2006,185 ( 1 ) : 165-172.
  • 8Morishige K, Shimokawa H, Matsumoto Y, et al. Overexpression of matrix metal- loproteinase-9 promotes intravaseular thrombus formation in porcine coronary ar- teries in vivo[J]. Cardiovasc Res,2003,57(2) :572-585.
  • 9Amalinei C, Caruntu ID, Giusca SE, et al. Matrix metalloproteinases involvement in pathologic conditions[J]. Rom J Morphol Embryol,2010,51 (2) :215-228.
  • 10Silence J, Collen D, Lijnen HR, et al. Reduced atherosclerotic plaque but en- hanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene[J]. Circ Res,2002,90(8):897-903.

同被引文献2

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部